a shortage of a testing componentis hobbling the u s battle against covid 19 as the number of confirmed coronavirus casesrises earlier testing was marred by problems that produced potentially inaccurate results as u s testing ramps up some labs have run short on the kits and components needed to determine whether samples taken from ailing patients confirm the presence of the novel coronavirus the number of confirmed covid 19 cases in the usarose to 1 050 and there have been29 deaths as of wednesday morning according to johns hopkins university in some cases the shortage prompted lab personnel to borrow components from colleagues using similar kits for testing unrelated to covid 19 saidmarc lipsitch a harvard university epidemiologist the extent of the problem could not immediately be determined what we need is a lot more testing right now lipsitch said but testing kits and components are in very short supply some of the testing componentsare manufactured by qiagen a multinational leader in molecular testing headquarteredin germany responding to spiking demand for its products the company increased production tothree shifts a day seven days a week at plants in germany and spain this now is an unprecedented situation said qiagen corporate spokesman thomas theuringer demand is exploding especially in the united states and this is stretching our capacity the centers for disease control and prevention is looking into the shortage director robertredfield told politico on tuesday i m confident of the actual test that we have but as people begin to operationalize the test they realize there s other things they need he said michael mina a harvard professor of epidemiology tweeted monday that the testing components are critical the shortage results in part from the increase in covid 19 testing across the usaafter a slow start due toproblemswith testing kitsfromthe cdc state and local health officials responded by callingon the federal government for authorization to use tests they developed that began in many places over the past week testing is done by health departments and clinical diagnostic laboratory giants such asquest diagnostics and laboratory corp of america testing for coronavirus typically uses reagents which are chemical substancesused in laboratory analyses the reagents extract purify and stabilize rna or ribonucleic acid in samples taken from patients suspected of having covid 19 that s the first step in confirming orruling out atentative diagnosis qiagensays itleads the world in this type of testing testing demand has led to a shortage of reagents for the rna extraction process said dr eric blank the chief program officer for the association of public health laboratories which represents state and local governmental health laboratories in the usaand responds to disease outbreaks we are now in the phase of the response where demand for testing is greater than the tests available even when the private commercial sector is doing testing blank said in an email the society for microbiology posted a warning on its website that the shortage could delay covid 19 testing we are deeply concerned that as the number of tests increases dramatically over the coming weeks clinical labs will be unable to deploy them without these critical components the microbiology group said state by state list of confirmed cases tracking the outbreak covid 19 positive tests will spike former fda chief warns of spike in us coronavirus cases along with increasing its production qiagen hiredmore employees andincreasedmanufacturing at afacility in germantown maryland given our ongoing supply to the united states theuringer said we are now working directly with the customers to understand their flexibility and specific needs in order to be able to ensure broad availability of our products 